Tina Sichrovsky, MD
Clinical Cardiac Electrophysiology · Ridgewood, NJNPI 1558567206
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 28.5% of the total. Reporting peaked in 2019 at $4,034 and has fallen 73.6% since, to $1,065 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.
Across 200 payments — averaging $55.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Philips North America LLC$2K
- Atricure, Inc.$1K
- Medtronic$1K
- Amgen$1K
- Abbott$806
- plus $2K from 13 others
Across 11 payments — averaging $4054.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$45K
What the payments were for
- Consulting fees$2,47522%
- Travel & lodging$3,85034%
- Food & beverage$4,87144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 107 | $3,195 |
| Philips North America LLC | 3 | $2,218 |
| Atricure, Inc. | 8 | $1,318 |
| Medtronic(2 entities) | 9 | $1,114 |
| Amgen | 10 | $1,031 |
| Abbott | 16 | $806 |
| Stereotaxis Inc | 4 | $627 |
| Biosense Webster, Inc. | 4 | $228 |
| Cardiva Medical, Inc. | 6 | $126 |
| Johnson & Johnson | 10 | $122 |
| Irhythm Technologies, Inc. | 7 | $115 |
| Gilead | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 4 | $56 |
| Abiomed | 2 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Novo Nordisk | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IGT D Peripheral$2,000
- EMBLEM$1,240
- SYNERGY ABLATION SYSTEM$764
- Niobe$515
- Micra$475
- AVEIR$402
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$310
- COBALT DR MRI SURESCAN$179
- ARCTIC FRONT ADVANCE$149
- Claria MRI$147
- GENERAL - THERAPIES$135
- Carto 3$124
- EPD Solutions Und$110
- EPD KODEX Procedure$107
How this compares
$11,197 in reported general payments places this provider in the 40th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 172 | $186,660 |
| XareltoRivaroxaban | 99 | $120,410 |
| MultaqDronedarone Hcl | 24 | $42,978 |
| Ranolazine ErRanolazine | 119 | $14,918 |
| EntrestoSacubitril/Valsartan | 20 | $12,538 |
| Dofetilide | 26 | $2,612 |
| Flecainide Acetate | 44 | $2,568 |
| Metoprolol Succinate | 118 | $2,102 |
| Amiodarone Hcl | 61 | $1,652 |
| Mexiletine Hcl | 11 | $1,623 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $1,325 |
| SotalolSotalol Hcl | 15 | $328 |
| Amlodipine Besylate | 34 | $261 |
| Atenolol | 11 | $247 |
| Carvedilol | 23 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $186,660172 claims |
| Johnson & JohnsonXarelto | $122 | $120,41099 claims |
| Sanofi-aventis U.S. LLCMultaq | $31 | $42,97824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Ridgewood
- Jonathan SteinbergRidgewood$85K
- Dan MusatRidgewood$27K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.